This is exactly the kind of binary construction that to me is irrelevant to B given the Phase 2a outcomes. There are many more outcomes possible than 2 just in the conditions you set. After all, in what ways superior? Lower, single dose with higher efficacy measured by sustained tissue repair and healing? Superior with same efficacy in a single dose? Superior in a 3 day course as opposed to a 7 day course, but the same sustained efficacy?
I can go on....
Let's name 2 scenarios and get opinions on what the approval process would be...